StratifiCare

StratifiCare

StratifiCare is a game-changing medical diagnostics company that is committed to improving patient outcomes through cutting-edge predictive protein diagnostics and AI technology. Founded with the vision of empowering personalized medicine for tomorrow, StratifiCare has been on the mission to develop quality, innovative diagnostic tests to enable healthcare providers in delivering personalized curative therapies to every patient since 2015.

Its pipeline includes ground-breaking tests that can predict life-threatening complications from severe Dengue, and the effectiveness of internal radiation therapy on liver cancer patients. Its diverse team is passionate about making a positive social impact on patients, their families, and society as a whole, and pledges to contribute towards the United Nations Sustainable Development Goals and the World Bank/IFC Ethical Principles in Health Care (EPiHC).

VISIT WEBSITE

For further enquiry, please contact Anthony Chua (Co-founder & CEO)

Subscribe To Our Newsletter

Join our mailing list to get updated with our latest news and events!

Contact Information
  • Lee Kong Chian School of
    Medicine,
    Clinical Sciences Building
    11 Mandalay Road #16-01
    Singapore 308232

  • +65 6904 1401
Members Login

co11ab Novena (co11ab) is a Bio MedTech incubator – forged through a tripartite alliance between Nanyang Technological University, Singapore (NTU Singapore), Agency for Science, Technology, and Research (A*STAR), and National Healthcare Group (NHG) – which aims to nurture and support the translational development of biomedical technologies. Our key focus areas are biotech, medtech and digital health.